High versus low-dose caffeine for apnea of prematurity: a randomized controlled trial
- 2.9k Downloads
The optimum caffeine dose in preterm infants has not been well investigated. We aimed to compare the efficacy and safety of high versus low-dose caffeine citrate on apnea of prematurity (AOP) and successful extubation of preterm infants from mechanical ventilation. We compared high-dose (loading 40 mg/kg/day and maintenance of 20 mg/kg/day) versus low-dose (loading 20 mg/kg/day and maintenance of 10 mg/kg/day) caffeine citrate in preterm infants <32 weeks gestation, presented with AOP within the first 10 days of life. A total of 120 neonates (60 in each group) were enrolled. High-dose caffeine was associated with a significant reduction in extubation failure in mechanically ventilated preterm infants (p < 0.05), the frequency of apnea (p < 0.001), and days of documented apnea (p < 0.001). High-dose caffeine was associated with significant increase in episodes of tachycardia (p < 0.05) without a significant impact on physician decision to withhold caffeine.
What is Known:
• Caffeine therapy for treatment of apnea of prematurity has been well established over the past few years. The optimal loading and maintenance dose of caffeine in preterm infants is not well-studied.
What is New:
• This double blind randomized controlled trial demonstrated that using a higher, than current standard, loading and maintenance doses of caffeine for treatment of apnea in preterm infants is well tolerated and significantly decrease the frequency of apnea.
KeywordsApnea Caffeine Mechanical ventilation Neonatal respiratory distress syndrome Preterm infant Xanthines
Apnea of prematurity
Caffeine for apnea of prematurity
Continuous positive airway pressure
Retinopathy of prematurity
We would like to thank the parents and families in the Neonatal Intensive Care Unit at Mansoura University Children’s Hospital. We thank Eetemad Arafa for her assistance with randomization, blinding, and drug preparation.
Conflict on interest
Authors declare that they have no significant competing financial, professional, or personal interests that might have influenced the performance or presentation of the work described in this manuscript.
No funding sources.
Sameh Mohammed participated in design of the study, data collection, and writing the first draft of the manuscript; Islam Nour participated in design of the study, data collection, data interpretation, and writing the manuscript; Abd Elazeez Shabaan participated in design of the study, data collection, and writing of the manuscript; Basma Shouman participated in design of the study, data collection, and writing of the manuscript; Hesham Abdel-Hady participated in design of the study, data collection, and writing of the manuscript; and Nehad Nasef participated in formulating the hypothesis, design of the study, data collection, data interpretation, statistical analysis, and writing of the manuscript. All should approve the final version of the manuscript.
- 10.Henderson-Smart D (1986) Pulmonary disease in the newborn. In: Textbook of neonatology. Churchill livingstone, MelbourneGoogle Scholar
- 12.Henderson-Smart DJ, and Davis PG (2010). Prophylactic methylxanthines for endotracheal extubation in preterm infants. Cochrane Database Syst Rev CD000139Google Scholar
- 13.Henderson-Smart DJ, and De Paoli AG (2010). Methylxanthine treatment for apnoea in preterm infants. Cochrane Database Syst Rev CD000140Google Scholar
- 14.Henderson-Smart DJ, and Steer PA (2010). Caffeine versus theophylline for apnea in preterm infants. Cochrane Database Syst Rev CD000273.Google Scholar
- 20.Martin RJ, Abu-Shaweesh JM, and Baird TM (2004). Apnoea of prematurity. Paediatr Respir Rev 5 Suppl A: S377-382.Google Scholar
- 33.Steer P, Flenady V, Shearman A, Charles B, Gray PH, Henderson-Smart D, Bury G, Fraser S, Hegarty J, Rogers Y, Reid S, Horton L, Charlton M, Jacklin R, Walsh A (2004) High dose caffeine citrate for extubation of preterm infants: a randomised controlled trial. Arch Dis Child Fetal Neonatal Ed 89:F499–F503PubMedCentralPubMedCrossRefGoogle Scholar
- 35.Shah VA, and Wai WC (2011). Effectivenes and side effects of 2 different doses of caffeine citrate in preventing apnea in VLBW premature infants. In: Hot Topics in Neonatology. Washington/DC: Nemours EducationGoogle Scholar